Interested in Eli Lilly and Company? Here are five stocks we like better.
The healthcare sector offers options for investors of every age, combining high-growth drugmakers, defensive operators, and reliable dividend payers.
Eli Lilly suits younger investors with its obesity and diabetes drug pipeline driving growth, having gained nearly 34% since its April low.
UnitedHealth Group fits middle-aged investors with a turnaround story and rising dividend, while Johnson & Johnson's Dividend King status appeals to older, income-focused investors.
When it comes to investing, there is no one-size-fits-all approach. Strategies vary based on numerous factors, including but not limited to investors' risk tolerance, net worth, and age. When it comes to stock-picking, that last one is important.
#comes #here #april
The healthcare sector offers options for investors of every age, combining high-growth drugmakers, defensive operators, and reliable dividend payers.
Eli Lilly suits younger investors with its obesity and diabetes drug pipeline driving growth, having gained nearly 34% since its April low.
UnitedHealth Group fits middle-aged investors with a turnaround story and rising dividend, while Johnson & Johnson's Dividend King status appeals to older, income-focused investors.
When it comes to investing, there is no one-size-fits-all approach. Strategies vary based on numerous factors, including but not limited to investors' risk tolerance, net worth, and age. When it comes to stock-picking, that last one is important.
#comes #here #april
2 months ago
